A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development

Genes and Development

Volumn 13, Issue 8, 1999, Pages 1025-1036

  Ducy, Patricia ^a   Starbuck, Michael ^a,b   Priemel, Matthias ^c   Shen, Jianhe ^a   Pinero, Gerald ^d   Geoffroy, Valerie ^b   Amling, Michael ^c   Karsenty, Gerard ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF HAMBURG   (Germany)

^d UNIVERSITY OF TEXAS DENTAL BRANCH AT HOUSTON   (United States)

Author keywords

Bone formation; Cbfa1; Cbfa1 autoregulation; Dominant negative; Osteoblast function

Indexed keywords

ANIMAL CELL; ARTICLE; AUTOREGULATION; CELL DIFFERENTIATION; EMBRYO DEVELOPMENT; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL;

ANIMALIA; MAMMALIA; MUS MUSCULUS;

EID: 0033560784     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.8.1025     Document Type: Article

References (55)

1. Amling M, L. Neff, S. Tanaka, D. Inoue, K. Kuida, E. Weir, W. M. Philbrick, A.E. Broadus, and R. Baron. 1997. Bcl-2 lies downstream of parathyroid hormone related peptide in a signalling pathway that regulates chondrocyte maturation during skeletal development. J. Cell Biol. 136: 205-213.
2. Aranson, B.D., A.L. Fisher, K. Blechman, M. Caudy, and J.P. Gergen. 1997. Groucho-dependent and -independent repression activities of Runt domain proteins. Mol. Cell. Biol. 17: 5581-5587.
3. Aubin, J.E. and F. Liu. 1996. The osteoblast lineage. In Principles of bone biology (ed. J.P. Bilezikian, L.G. Raisz, and G.A. Rodan), pp. 51-67. Academic Press, San Diego, CA.
4. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl. 1995. Current protocols in molecular biology. John Wiley & Sons, New York, NY.
5. Bancroft, J.D. and A. Stevens. 1996. Theory and practice of histological techniques. Churchil Livingston, New York, NY.
6. Bae, S.-C., Y. Yamaguchi-Iwai, E. Ogawa, M. Maruyama, M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y. Ito. 1992. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene. Oncogene 8: 809-814.
7. Bae, S.-C., E. Ogawa, M. Maruyama, H. Oka, M. Satake, K. Shigesada, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, and Y. Ito. 1994. PEBP2αB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol. Cell. Biol. 14: 3242-3252.
8. Bae, S.-C., E-I. Takahashi, Y.W. Zhang, E. Ogawa, K. Shigesada, Y. Namba, M. Satake, and Y. Ito. 1995. Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian runt domain. Gene 159: 245-248.
9. Bianco, P., L.W. Fisher, M.F. Young, J.D. Termine, and P. Gehron Robey. 1991. Expression of bone sialo protein (BSP) in developing human tissues. Calcif. Tissue Int. 49: 421-426.
10. Bonnerot, C. and J.F. Nicolas. 1993. Guide to techniques in mouse development. Methods Enzymol. 225: 747-799.
11. Bucay, N., I. Sarosi, C.R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. Lin Tan, W. Xu, D.L. Lacey, W.J. Boyle, and S. W Simonet. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes & Dev. 12: 1260-1268.
12. Byers, P.H. 1990. Brittle bones - fragile molecules: Disorders of collagen gene structure and expression. Trends Genet. 6: 293-300.
13. Denhardt, D.T. and X. Guo. 1993. Osteopontin: A protein with diverse functions. FASEB J. 7: 1475-1482.
14. Deryckere, F. and F. Gannon. 1994. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. BioTechniques 16: 405.
15. Desbois, C., D.A. Hogue, and G. Karsenty. 1994. The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression. J. Biol. Chem. 269: 1183-1190.
16. Ducy, P. and G. Karsenty. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15: 1858-1869.
17. Ducy, P., C. Desbois, B. Boyce, G. Pinero, B. Story, C. Dunstan, E. Smith, J. Bonadio, S. Goldstein, C. Gundberg, A. Bradley, and G. Karsenty. 1996. Increased bone formation in osteocalcin-deficient mice. Nature 382: 448-452.
18. Ducy, P., R. Zhang, V. Geoffroy, A. Ridall, and G. Karsenty. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
19. Frendo, J-L., G. Xiao, R.T. Franceschi, G. Karsenty, and P. Ducy. 1998. Functional hierarchy between two OSE2 elements in the control of Osteocalcin gene expression in vivo. J. Biol. Chem. 273: 30509-30516.
20. Gehron-Robey, P. 1996. Bone matrix proteoglycans and glycoproteins. In Principles of bone biology (ed. J.P. Bilezikian, L.G. Raisz, and G.A. Rodan), pp. 155-166. Academic Press, San Diego, CA.
21. Goldberg, H., T. Helaakoski, L.A. Garrett, G. Karsenty, A. Pellegrino, G. Lozano, S. Maity, and B. de Crombrugghe. 1992. Tissue-specific expression of the mouse α2(I) collagen promoter: Studies in transgenic mice and in tissue cultured cells. J. Biol. Chem. 267: 19622-19630.
22. Hahn, M., M. Vogel, and G. Delling. 1991. Undecalcified preparation of bone tissue: Report of technical experience and development of new methods. Virchows Archiv. A Pathol. Anat. 418: 1-7.
23. Hauschka, P., J. Lian, D. Cole, and C. Gundberg. 1989. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol. Rev. 69: 990-1047.
24. Hogan, B.L.M. 1996. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes & Dev. 10: 1580-1594.
25. Kleerekoper M. and L.V. Avioli. 1998. Osteoporosis pathogenesis and therapy. In Metabolic bone disease (ed. L.V. Avioli and S.M. Krane), pp. 387-389. Academic Press, San Diego, CA.
26. Kochhar, D.M. 1973. Limb development in mouse embryos. Analysis of teratogenic effects of retinoic acid. Teratology 7: 289-298.
27. Komori, T. , H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R.T. Bronson, Y.H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, and T. Kishimoto. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
28. Kurokawa, M., T. Tanaka, K. Tanaka, N. Hirano, S. Ogawa, K. Mitani, Y. Yazaki, and H. Hirai. 1996. A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA-binding ability and the transforming activity on fibroblasts. J. Biol. Chem. 271: 16870-16876.
29. Lacey, D.L., E. Timms, H-L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliot, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y-X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, and W.J. Boyle. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
30. Lee, B., K. Thirunavukkarasu, L. Zhou, L. Pastore, A. Baldini, J. Hecht, V. Geoffroy, P. Ducy, and G. Karsenty. 1997. Missense mutations abolishing DNA binding OSF2/CBFA1 in patients affected with cleidocranial dysplasia. Nat. Genet. 16: 307-311.
31. Marie, P. and P. Santon. 1898. Sur la dysostose cleidocrannienne hereditaire. Rev. Neurol. 6: 835-838.
32. Mizushima, S. and S. Nagata. 1990. pEF-BOS, a powerful mamalian expression vector. Nucleic Acids Res. 18: 5322.
33. Mundlos, S. and B.R. Olsen. 1997. Heritable diseases of the skeleton. Part I: Molecular insights into skeletal developmenttranscription factors and signaling pathways. FASEB J. 11: 125-132.
34. Mundlos, S., F. Otto, C. Mundlos, J.B. Mulliken, A.S. Aylsworth, S. Albright, D. Lindhout, W.G. Cole, W. Henn, J.H.M. Knoll, M.J. Owen, R. Mertelsmann, B.U. Zabel, and B.R. Olsen. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773-779.
35. Nagata, S., M. Tsuchiya, T. Yamazaki, O. Yamamoto, Y. Hirata, N. Kubota, M. Oheda, H. Nomura, and M Ono. 1986. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319: 415-418.
36. Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito. 1993. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. 90: 6859-6863.
37. Ott, S.M. 1996. Theoritical and methodoligical approach. In Principles of bone biology (ed. J.P. Bilezikian, L.G. Raisz, and G.A. Rodan), pp. 231-234. Academic Press, San Diego, CA.
38. Otto, F., A.P. Thornell, T. Crompton, A. Denzel, K.C. Gilmour, I.R. Rosewell, G.W.H. Stamp, R.S.P. Beddington, S. Mundlos, B.R. Olsen, P.B. Selby, and M.J. Owen. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
39. Owen, T.A., M. Aronow, V. Shalhoub, L.M. Barone, L. Wilming, M.S. Tassinari, M.B. Kennedy, S. Pockwinse, J.B. Lian, and G.S. Stein. 1990. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell Physiol. 143: 420-430.
40. Parfitt, A.M., M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunier, S. M. Ott, and R.R. Recker. 1987. Bone histomorphometry. Standardization of nomenclature, symbols, and units. J. Bone Miner. Res. 2: 595-610.
41. Pereira, L., K. Andrikopoulos, J. Tian, S.Y. Lee, D.R. Keene, R. Ono, D.P. Reinhardt, L.Y. Sakai, N.J. Biery, T. Bunton, H.C. Dietz, and F. Ramirez. 1997. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat. Genet. 17: 218-222.
42. Prockop, D.J. and K.I. Kivirikko. 1984. Heritable diseases of collagen. New Engl. J. Med. 311: 376-386.
43. Rittling, S.R., H.N. Matsumoto, M.D. McKee, A. Nanci, X-R. An, K.E. Novick, A.J. Kowalski, M. Noda, and D.T. Denhardt. 1998. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 13: 1101-1111.
44. Rowe D.W. and J.R. Shapiro. 1998. Osteogenesis imperfecta. In Metabolic bone disease (ed. L.V. Avioli and S.M. Krane), pp. 651-678. Academic Press, San Diego, CA.
45. Simeone, A., A. Daga, and F. Calabi. 1995. Expression of runt in the mouse embryo. Devel. Dyn. 203: 61-70.
46. Simonet, W.S., D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, R. Luthy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, R. Elliott, A. Colombero, H.L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T.M. Hughes, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van, J. Tarpley, P. Derby, R. Lee, Amgen EST Program, and W.J. Boyle. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
47. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the C-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
48. Soule A.B. 1946. Mutational dysostosis (Cleidocranial dysostosis). J. Bone Joint Surg. 1: 81-102.
49. Stein, G.S., J.B. Lian, and T.A. Owen. 1990. Bone cell differentiation: A functionally coupled relationship between expression of cell-growthand tissue-specific genes. Curr. Opin. Cell Biol. 2: 1018-1027.
50. Stein, G.S., J.B. Lian, J.L. Stein, A.J. van Wijnen, B. Frenkel, and M. Montecino. 1996. Mechanisms regulating osteoblast proliferation and differentiation. In Principles of bone biology (ed. J.P. Bilezikian, L.G. Raisz, and G.A. Rodan), pp. 69-86. Academic Press, San Diego, CA.
51. Thirunavukkarasu, K., M. Mahajan, K.W. McLarren, S. Stifani, and G. Karsenty. 1998. Two domains unique to osteoblastspecific transciption factor Cbfa1/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfb. Mol. Cell. Biol. 18: 4197-4208.
52. Tracey, W.D. Jr, M.E. Pepling, M.E. Horb, G.H. Thomsen, and J.P. Gergen. 1998. A Xenopus homologue of aml-1 reveals unexpected patterning mechanisms leading to the formation of embryonic blood. Development 125: 1371-1380.
53. Vignery, A. and R. Baron. 1980. Dynamic histomorphometry of alveolar bone remodeling in the adult rat. Anat. Rec. 196: 191-200.
54. Wijmenga, C., N.A. Speck, N.C. Dracopoli, M.H. Hofker, P. Liu, and F.S. Collins. 1995. Identification of a new murine runt domain-containing gene, Cbf3a, and localization of the human homolog, CBF3A, to chromosome 1p35-pter. Genomics 26: 611-614.
55. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, and T. Suda. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. 95: 3597-3602.